Thanks for that BJ....people oughtta take into consideration how companies take heat for sloppy trials. .Not Cellceutix and Kevetrin. If it takes two to four more cohorts, we are looking at roughly March to finish up Phase 1. And results will be solid as a rock.

And responding to Seel, yes this last 24 hours has been pretty mind blowing....reading the slides last night was exciting enough, then to wake up to P21 news right at the wire....Wow.

I expected better price action but, hey it's an OTC stock, lots of resistance from the earlier tops, MM shorting,....Claytrader explained it pretty well....the street will "get it" eventually and our patience will be rewarded. Greatness ahead, I'm more convinced than ever.....